Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cellsAdam J. Lamble, Nirali N. Shah, Regina M. Myers et al.|Blood Advances|2022Cited by 149
R‐<scp>CHOP </scp><i>versus</i> dose‐adjusted R‐<scp>EPOCH</scp> in frontline management of primary mediastinal B‐cell lymphoma: a multi‐centre analysisNirav N. Shah, Jakub Svoboda, Anikó Szabó et al.|British Journal of Haematology|2017Cited by 101
Pediatric Aggressive Mature B-Cell Lymphomas, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyKimberly Davies, Deborah A. Freedman-Cass, Matthew J. Barth et al.|Journal of the National Comprehensive Cancer Network|2020Cited by 67
Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg CellsFrancesco Maura, Lisa Giulino‐Roth, Bachisio Ziccheddu et al.|Blood Cancer Discovery|2023Cited by 65
Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemiaSara Silbert, Marlie R. M. Provost, Alexander W. Rankin et al.|Blood|2025Cited by 33